Novel Therapeutic Approaches for Treatment of Cancer, 2018 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 20, 2018--The ” Novel Therapeutic Approaches for Treatment of Cancer ” report has been added to ResearchAndMarkets.com’s offering.
This Genetic Technology TOE depicts new life sciences trends across cancer treatment. Innovations related to the development of novel therapeutic approaches for the treatment of cancer, including senescent cells, CAR-T cell therapy, epitranscriptomics, and exosome production disruption, are profiled. The corresponding clinical trials scenario is also depicted.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
Key Topics Covered:
Recent Advances in Development of Novel Therapeutic Approaches for CancerTargeting Senescent Cells to Battle Cancer and Reverse Ageing Improvised CAR-T therapy for Solid Tumors Leveraging Epitranscriptomics to Develop Cancer Treatments Suppressing Cancer Metastasis by Disrupting Exosome Production
Clinical Trial Analysis and Key ContactsClinical Trial Analysis of Gene Therapy Treatments for Non-small Cell Lung Cancer (NSCLC) Key Contacts For more information about this report visit https://www.researchandmarkets.com/research/mnzt8v/novel_therapeutic?w=4.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180920005944/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Oncology Drugs
INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS GENETICS ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/20/2018 05:07 PM/DISC: 09/20/2018 05:07 PM